Insulin Glargine

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 83257-015
  • Package NDC 83257-015-31
  • Package NDC 83257-015-32
  • Application number BLA761201
  • SPL ID 1788fd3f-09d7-eb86-5e9e-db823fa41a8a
  • SPL set ID 3ac85ebb-5594-59c8-77fd-df254329d151
  • UNII 2ZM8CX04RZ
  • RxCUI 2563971
  • RxCUI 2563976

What the source publishes

Labeler
Biocon Biologics Inc.
Active ingredients
insulin Glargine-yfgn
Form
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:83257-015_1788fd3f-09d7-eb86-5e9e-db823fa41a8a
{
  "name": "Insulin Glargine",
  "splId": "1788fd3f-09d7-eb86-5e9e-db823fa41a8a",
  "labels": [
    {
      "setId": "3ac85ebb-5594-59c8-77fd-df254329d151",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3ac85ebb-5594-59c8-77fd-df254329d151",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3ac85ebb-5594-59c8-77fd-df254329d151"
    }
  ],
  "routes": [
    "SUBCUTANEOUS"
  ],
  "labeler": "Biocon Biologics Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 SYRINGE in 1 CARTON (83257-015-31)  / 3 mL in 1 SYRINGE",
      "package_ndc": "83257-015-31",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20230728"
    },
    {
      "sample": false,
      "description": "5 SYRINGE in 1 CARTON (83257-015-32)  / 3 mL in 1 SYRINGE",
      "package_ndc": "83257-015-32",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20230728"
    }
  ],
  "productId": "83257-015_1788fd3f-09d7-eb86-5e9e-db823fa41a8a",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, SOLUTION",
  "productNdc": "83257-015",
  "deaSchedule": null,
  "genericName": "insulin Glargine-yfgn",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "INSULIN GLARGINE",
      "strength": "100 [iU]/mL"
    }
  ],
  "applicationNumber": "BLA761201",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20230728",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "M0011417",
      "N0000175453"
    ],
    "unii": [
      "2ZM8CX04RZ"
    ],
    "rxcui": [
      "2563971",
      "2563976"
    ],
    "spl_set_id": [
      "3ac85ebb-5594-59c8-77fd-df254329d151"
    ],
    "pharm_class_cs": [
      "Insulin [CS]"
    ],
    "pharm_class_epc": [
      "Insulin Analog [EPC]"
    ],
    "manufacturer_name": [
      "Biocon Biologics Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:83257-015_1788fd3f-09d7-eb86-5e9e-db823fa41a8a"